RNAZ
Transcode Therapeutics, Inc.
NASDAQ · Healthcare · Biotechnology · US
$1.71
−0.58%0
Insider buys (3m)
0
Insider sells (3m)
$0.00
Net value (3m)
-65.2%
Price return (3m)
Form 4 filings
| Date | Insider | Activity | Shares | Price |
|---|---|---|---|---|
| Sep 11, 2026 | Fitzgerald Thomas A · director, officer: Chief Financial Officer | A-Award | 185,000 | $1.78 |
| Jun 18, 2024 | Manting Erik · director | A-Award | 70,000 | $1.20 |
| Jun 18, 2024 | Fitzgerald Thomas A · director, officer: Interim CEO, CFO | A-Award | 650,000 | $1.20 |
| Jun 18, 2024 | Calais Philippe · director | A-Award | 70,000 | $1.20 |
| Jun 18, 2024 | Marquet Magda · director | A-Award | 70,000 | $1.20 |
| Oct 2, 2023 | Dudley Robert Michael · director, officer: Chief Executive Officer | Purchase | 98,000 | $0.51 |
| Oct 2, 2023 | Fitzgerald Thomas A · director, officer: Chief Financial Officer | Purchase | 49,350 | $0.51 |
| Jun 22, 2023 | Dudley Robert Michael · director, officer: Chief Executive Officer | Purchase | 6,607 | $2.55 |
| Jun 22, 2023 | Dudley Robert Michael · director, officer: Chief Executive Officer | Purchase | 12,000 | $2.65 |
| Jun 14, 2023 | Dudley Robert Michael · director, officer: Chief Executive Officer | Purchase | 19,000 | $2.76 |
| Jun 13, 2023 | Dudley Robert Michael · director, officer: Chief Executive Officer | Purchase | 19,000 | $2.76 |
| May 19, 2023 | Marquet Magda · director | A-Award | 45,000 | $0.28 |
| May 19, 2023 | Fitzgerald Thomas A · director, officer: Chief Financial Officer | A-Award | 300,000 | $0.28 |
| May 19, 2023 | Dudley Robert Michael · director, officer: Chief Executive Officer | A-Award | 735,000 | $0.28 |
| May 19, 2023 | Calais Philippe · director | A-Award | 45,000 | $0.28 |
| May 19, 2023 | Manting Erik · director | A-Award | 45,000 | $0.28 |
| May 10, 2023 | Marquet Magda · director | A-Award | 9,500 | $0.30 |
| May 10, 2023 | Calais Philippe · director | A-Award | 9,500 | $0.30 |
| May 10, 2023 | Manting Erik · director | A-Award | 9,500 | $0.30 |
| Dec 14, 2022 | Dudley Robert Michael · officer: Chief Executive Officer | A-Award | 135,000 | $0.00 |
| Dec 14, 2022 | Medarova Zdravka · officer: Chief Technology Officer | A-Award | 60,000 | $0.00 |
| Dec 14, 2022 | Medarova Zdravka · officer: Chief Technology Officer | A-Award | 33,000 | $0.00 |
| Dec 14, 2022 | Fitzgerald Thomas A · officer: Chief Financial Officer | A-Award | 100,000 | $0.00 |
| Sep 16, 2022 | Dudley Robert Michael · director, 10 percent owner, officer: Chief Executive Officer | Purchase | 20,000 | $1.15 |
| Jun 22, 2022 | Marquet Magda · director: | A-Award | 9,500 | $0.00 |
| Jun 22, 2022 | Manting Erik · director: | A-Award | 9,500 | $0.00 |
| Jun 22, 2022 | Calais Philippe · director: | A-Award | 9,500 | $0.00 |
| Jun 17, 2022 | Fitzgerald Thomas A · officer: Chief Financial Officer | Purchase | 12,000 | $1.27 |
| Jun 1, 2022 | Dudley Robert Michael · officer: Chief Executive Officer | Purchase | 28,000 | $1.84 |
| Mar 2, 2022 | Fitzgerald Thomas A · officer: Chief Financial Officer | A-Award | 52,000 | $0.00 |
Institutional positioning
13F filings over the trailing two quarters
New 6Increased 3Reduced 2Sold out 2
| Filer | Action | Shares | Filed |
|---|---|---|---|
| Yorkville Advisors Global, LP | New Position | 19,639 | Aug 6, 2026 |
| GEODE CAPITAL MANAGEMENT, LLC | New Position | 12,740 | May 15, 2026 |
| UBS GROUP AG | Increased | 8,295 | May 5, 2026 |
| VANGUARD CAPITAL MANAGEMENT LLC | New Position | 6,545 | May 15, 2026 |
| VANGUARD CAPITAL MANAGEMENT LLC | Unchanged | 6,545 | Aug 13, 2026 |
| VANGUARD FIDUCIARY TRUST CO | Unchanged | 2,982 | Aug 13, 2026 |
| VANGUARD FIDUCIARY TRUST CO | New Position | 2,982 | May 8, 2026 |
| UBS Group AG | Reduced | 2,888 | Aug 13, 2026 |
| FMR LLC | New Position | 706 | Aug 13, 2026 |
| Tower Research Capital LLC (TRC) | Increased | 677 | Aug 11, 2026 |
| TOWER RESEARCH CAPITAL LLC (TRC) | Reduced | 228 | May 15, 2026 |
| WELLS FARGO & COMPANY/MN | Unchanged | 55 | Aug 14, 2026 |
| WELLS FARGO & COMPANY/MN | New Position | 55 | Jul 8, 2026 |
| SBI Securities Co., Ltd. | Unchanged | 12 | Jul 23, 2026 |
| SBI SECURITIES CO., LTD. | Increased | 12 | Apr 28, 2026 |
Insider activity from SEC Form 4; institutional positioning from 13F filings · Latest filing Sep 11, 2026